BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29961688)

  • 21. Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies.
    Migliaresi S; Picillo U; Ambrosone L; Di Palma G; Mallozzi M; Tesone ER; Tirri G
    Lupus; 1994 Feb; 3(1):37-41. PubMed ID: 8025584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study.
    Faezi ST; Hoseinian AS; Paragomi P; Akbarian M; Esfahanian F; Gharibdoost F; Akhlaghi M; Nadji A; Jamshidi AR; Shahram F; Nejadhosseinian M; Davatchi F
    Mod Rheumatol; 2015 Jul; 25(4):590-4. PubMed ID: 25528860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.
    Medlin JL; Hansen KE; McCoy SS; Bartels CM
    Semin Arthritis Rheum; 2018 Oct; 48(2):198-204. PubMed ID: 29550111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management.
    Zheng Y; Zheng Z; Zhang K; Zhu P
    Autoimmun Rev; 2022 Feb; 21(2):102992. PubMed ID: 34793961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Avascular (aseptic) bone necrosis in SLE and nephrotic syndrome following corticosteroid therapy (author's transl)].
    Inage H; Koyama A; Narita M; Tojo S; Iesato K; Takei I; Wakasin Y; Wakasin M
    Nihon Jinzo Gakkai Shi; 1980 Apr; 22(4):393-9. PubMed ID: 7401392
    [No Abstract]   [Full Text] [Related]  

  • 26. Unusual high frequency of multifocal lesions of osteonecrosis in a young patient with systemic lupus erythematosus.
    Guillaume MP; Brandelet B; Peretz A
    Br J Rheumatol; 1998 Nov; 37(11):1248-9. PubMed ID: 9851281
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence and risk factors for serositis in patients with systemic lupus erythematosus: A case-control study.
    Gimeno-Torres L; Carrión-Barberà I; Durán X; Villegas E; Monfort J; Salman-Monte TC
    Lupus; 2021 Nov; 30(13):2095-2101. PubMed ID: 34794346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of osteonecrosis in systemic lupus erythematosus: a review.
    Ehmke TA; Cherian JJ; Wu ES; Jauregui JJ; Banerjee S; Mont MA
    Curr Rheumatol Rep; 2014; 16(9):441. PubMed ID: 25074031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII.
    Cheng C; Huang C; Chen Z; Zhan F; Duan X; Wang Y; Zhao C; Wu Z; Xu J; Li H; Yang M; Wu R; Zhao J; Zhang S; Wang Q; Leng X; Tian X; Li M; Zeng X
    Arthritis Res Ther; 2023 May; 25(1):78. PubMed ID: 37173771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid.
    Doğan I; Kalyoncu U; Kiliç L; Akdoğan A; Karadağ Ö; Kiraz S; Bilgen ŞA; Ertenli I
    Turk J Med Sci; 2020 Feb; 50(1):219-224. PubMed ID: 31905492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
    Calvo-Alén J; McGwin G; Toloza S; Fernández M; Roseman JM; Bastian HM; Cepeda EJ; González EB; Baethge BA; Fessler BJ; Vilá LM; Reveille JD; Alarcón GS;
    Ann Rheum Dis; 2006 Jun; 65(6):785-90. PubMed ID: 16269429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
    Merayo-Chalico J; Barrera-Vargas A; Morales-Padilla S; la Garza RR; Vázquez-Rodríguez R; Campos-Guzmán J; Alcocer-Varela J; Sotomayor M; Abud-Mendoza C; Martínez-Martínez M; Colunga-Pedraza I; Uriarte-Hernández C; Acosta-Hernández R; Fajardo D; García-García C; Padilla-Ortíz D; Gómez-Martín D
    J Rheumatol; 2019 Apr; 46(4):397-404. PubMed ID: 30647184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for osteonecrosis in systemic lupus erythematosus.
    Mont MA; Glueck CJ; Pacheco IH; Wang P; Hungerford DS; Petri M
    J Rheumatol; 1997 Apr; 24(4):654-62. PubMed ID: 9101497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities.
    Nagasawa K; Ishii Y; Mayumi T; Tada Y; Ueda A; Yamauchi Y; Kusaba T; Niho Y
    Ann Rheum Dis; 1989 Aug; 48(8):672-6. PubMed ID: 2506841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease activity as a major risk factor for osteonecrosis in early systemic lupus erythematosus.
    Fialho SC; Bonfá E; Vitule LF; D'Amico E; Caparbo V; Gualandro S; Pereira RM
    Lupus; 2007; 16(4):239-44. PubMed ID: 17439929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus.
    Shah M; Chaudhari S; McLaughlin TP; Kan HJ; Bechtel B; Dennis GJ; Molta CT
    Clin Ther; 2013 Apr; 35(4):486-97. PubMed ID: 23587268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Damage in systemic lupus erythematosus and its association with corticosteroids.
    Zonana-Nacach A; Barr SG; Magder LS; Petri M
    Arthritis Rheum; 2000 Aug; 43(8):1801-8. PubMed ID: 10943870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors.
    Gladman DD; Dhillon N; Su J; Urowitz MB
    Lupus; 2018 Jan; 27(1):76-81. PubMed ID: 28530464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors for Symptomatic Avascular Necrosis in Childhood-onset Systemic Lupus Erythematosus.
    Yang Y; Kumar S; Lim LS; Silverman ED; Levy DM
    J Rheumatol; 2015 Dec; 42(12):2304-9. PubMed ID: 26568601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.
    Mont MA; Pivec R; Banerjee S; Issa K; Elmallah RK; Jones LC
    J Arthroplasty; 2015 Sep; 30(9):1506-1512.e5. PubMed ID: 25900167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.